Tradestie Institutional Equity Comparison Engine

SANA vs VSTM โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SANA Overall Edge

SANA Captures Institutional Edge (2โ€“1 Pillars ยท 3โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Sana Biotechnology, Inc. Common Stock (SANA) driven by superior Growth & Margin, Options & Structure while VSTM counters with relative strength in Momentum & Technical. Fundamentally, SANA trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus VSTM at N/M Forward P/E and -193.7% operating margin (+113.6% YoY). In options structure, SANA sits in BREAKDOWN (4th %ile IV; Dealer Gamma Walls on Pro) against VSTM sits in CONSOLIDATION (8th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
SANA N/M vs VSTM N/M Fwd P/E
Growth & Margin Winner SANA
Op Margin 0.0% vs -193.7% ยท YoY +0.0% vs +113.6%
Momentum & Technical Winner VSTM
1Y -48.6% vs -5.1% ยท 52W Pos 1% vs 58%
Options & Structure Winner SANA
BREAKDOWN (4th %ile IV) vs CONSOLIDATION (8th %ile IV)
SANA NASDAQ
Sana Biotechnology, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$1.88
-6.93% 1D
Market Cap $605.3M
1M Return -17.18%
1Y Return -48.63%
Forward P/E N/M
Unified AI Score
44.3 / 100 HOLD
Tech 33.0 Fund 51.0 Flow 66.0 Mom 60.0
VSTM NASDAQ
Verastem, Inc.
Pharmaceutical Preparations
$7.70
-5.87% 1D
Market Cap $1.0B
1M Return -10.98%
1Y Return -5.06%
Forward P/E N/M
Unified AI Score
56.9 / 100 HOLD
Tech 33.0 Fund 51.0 Flow 64.0 Mom 70.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SANA -48.63% VSTM -5.06% Spread: +43.57 pp (VSTM Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
SANA TTM Op. Margin: 0.0% VSTM TTM Op. Margin: -193.7%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SANA vs VSTM. Trailing 12-month operating profitability (SANA 0.0% vs VSTM -193.7%) and valuation multiples (SANA N/M vs VSTM N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SANA (3) vs VSTM (5)
Institutional Metric SANA VSTM Criterion Row Winner
Market Capitalization Scale $605.3M $1.0B Larger Scale VSTM
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +113.6% Higher Growth VSTM
Operating Margin (TTM) Profitability 0.0% -193.7% Higher Margin SANA
Net Profit Margin Profitability 0.0% -178.4% Higher Margin SANA
Return on Equity (ROE) Capital Efficiency -79.5% -471.2% Higher ROE SANA
52-Week Range Position Momentum 1% ($2โ€“$5) 58% ($3โ€“$11) Stronger Trend VSTM
Beta / 30D Volatility Risk Regime 1.82ฮฒ ยท 78% Vol 1.11ฮฒ ยท 71% Vol Lower Realized Risk VSTM
Unified Institutional Score Composite Signal 44.3 / 100 (HOLD) 56.9 / 100 (HOLD) Higher Composite VSTM

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SANA vs VSTM Buy Guide
SANA BREAKDOWN
57d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 4th %ile
IV Regime Compressed (<25th %ile)
Live SANA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
VSTM CONSOLIDATION
50d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 8th %ile
IV Regime Compressed (<25th %ile)
Live VSTM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SANA nor VSTM registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.